Login
Israel-Hamas Conflict
World Cup
Military
Social Media
Benjamin Netanyahu
Motorsports
Donald Trump
Parade
Artificial Intelligence
Soccer
South America
Cryptocurrency
Immigration
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

AI-Derived Therapy for IPF Shows Potential in Phase 2a Trial

Summary by ajmc.com
The potential therapy for idiopathic pulmonary fibrosis is notable because not only was the small molecule discovered by artificial intelligence, but the drug’s target itself was, too.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
ajmc.comajmc.com

AI-Derived Therapy for IPF Shows Potential in Phase 2a Trial

The potential therapy for idiopathic pulmonary fibrosis is notable because not only was the small molecule discovered by artificial intelligence, but the drug’s target itself was, too.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

ajmc.com broke the news in on Saturday, June 14, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Artificial Intelligence

Artificial Intelligence

News
For You
SearchBlindspotLocal